SCIENCE BEHIND SARDS TREATMENT
IVIg AND SARDS TREATMENT?
Intravenous immunoglobulin (IVIg) is a treatment utilized for aggressive autoimmune diseases that do not respond well to standard immunosuppressive medications. It contains a mixture of antibodies, also known as immunoglobulins, derived from the plasma of many healthy donors. These immunoglobulins are proteins that the immune system uses to control the excessive activation of immune cells and complement.
​
In autoimmune diseases, IVIg can help to dampen the overactive immune response, reducing inflammation and blocking the autoantibodies that may be causing damage. Both our scientific research and the studies of other investigators indicate that autoantibodies against retinal tissue are frequently present in SARDS patients and could potentially be responsible for the acute progression of retinal damage and blindness. For more information please read our published work on the subject and listen to our scientific conference presentations.